Pilot Study of Lidocaine 5% Patch Versus Placebo in Patients With Osteoarthritis Pain of the Knee

Completed · Phase 2 · Has a placebo group

Conditions studied: Osteoarthritis, Knee

In brief

Patients with unilateral or bilateral osteoarthritis (OA) of the knee participated in a Phase II clinical trial to assess the efficacy of lidocaine 5% patch compared with placebo in the treatment of pain from OA of the knee.

Key facts

Study ID

NCT00904462

Run by

Endo USA Inc., a Keenova Therapeutics Company

People needed

224

Starts

2004-08-01

Last updated by the study team

2010-02-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Hueytown, Alabama, United States
• Study site — Tallassee, Alabama, United States
• Study site — Phoenix, Arizona, United States
• Study site — Boulder, Colorado, United States
• Study site — DeLand, Florida, United States
• Study site — Largo, Florida, United States
• Study site — Palm Harbor, Florida, United States
• Study site — St. Petersburg, Florida, United States
• Study site — Chicago, Illinois, United States
• Study site — Springfield, Illinois, United States
• Study site — Wheaton, Maryland, United States
• Study site — Peabody, Massachusetts, United States
• Study site — Bingham Farms, Michigan, United States
• Study site — Reno, Nevada, United States
• Study site — Berlin, New Jersey, United States
• Study site — Dayton, Ohio, United States
• Study site — Oklahoma City, Oklahoma, United States
• Study site — Duncansville, Pennsylvania, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Charleston, South Carolina, United States
• Study site — Bartlett, Tennessee, United States
• Study site — Cordova, Tennessee, United States
• Study site — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.